Articles dans des revues avec comité de lecture (253)
  1. 179. Castañé, A., Valjent, E., Ledent, C., Parmentier, M., Maldonado, R., & Valverde, O. (2002). Lack of CB1 cannabinoid receptors modifies nicotine behavioural responses, but not nicotine abstinence. Neuropharmacology, 43(5), 857-867.
  2. 180. Haller, J., Bakos, N., Szirmay, M., Ledent, C., & Freund, T. F. (2002). The effects of genetic and pharmacological blockade of the CB1 cannabinoid receptor on anxiety. European journal of neuroscience, 16(7), 1395-1398. doi:10.1046/j.1460-9568.2002.02192.x
  3. 181. Van De Wiele, C. J., Vaughn, J. G., Blackburn, M. R., Ledent, C., Jacobson, M. A., Jiang, H., & Thompson, L. F. (2002). Adenosine kinase inhibition promotes survival of fetal adenosine deaminase-deficient thymocytes by blocking dATP accumulation. The Journal of clinical investigation, 110(3), 395-402. doi:10.1172/JCI15683
  4. 182. Prentice, D. J., Kelly, M., Ledent, C., & Hourani, S. (2002). Relaxation of the mouse isolated aorta and carotid artery in response to adenosine analogues in genetically-modified mice lacking the adenosine A(2A) receptor. Naunyn-Schmiedeberg's archives of pharmacology, 366(2), 127-133. doi:10.1007/s00210-002-0581-7
  5. 183. Dremier, S., Coulonval, K., Perpete, S., Vandeput, F., Fortemaison, N., Van Keymeulen, A., Deleu, S., Ledent, C., Clément, S., Schurmans, S., Dumont, J. E., Lamy, F., Roger, P. P., & Maenhaut, C. (2002). The role of cyclic AMP and its effect on protein kinase A in the mitogenic action of thyrotropin on the thyroid cell. Annals of the New York Academy of Sciences, 968, 106-121. doi:10.1111/j.1749-6632.2002.tb04330.x
  6. 184. Talukder, M. A. H., Morrison, R. R., Jacobson, M. A., Jacobson, K. A., Ledent, C., & Mustafa, S. J. (2002). Targeted deletion of adenosine A(3) receptors augments adenosine-induced coronary flow in isolated mouse heart. American journal of physiology. Heart and circulatory physiology, 282(6), H2183-H2189. doi:10.1152/ajpheart.00964.2001
  7. 185. Maccarrone, M., Valverde, O., Barbaccia, M. L., Castañé, A., Maldonado, R., Ledent, C., Parmentier, M., & Finazzi-Agrò, A. (2002). Age-related changes of anandamide metabolism in CB1 cannabinoid receptor knockout mice: correlation with behaviour. European journal of neuroscience, 15(7), 1178-1186. doi:10.1046/j.1460-9568.2002.01957.x
  8. 186. Monory, K., Tzavara, E. T., Lexime, J., Ledent, C., Parmentier, M., Borsodi, A., & Hanoune, J. (2002). Novel, not adenylyl cyclase-coupled cannabinoid binding site in cerebellum of mice. Biochemical and biophysical research communications, 292(1), 231-235. doi:10.1006/bbrc.2002.6635
  9. 187. Brooks, J. W., Pryce, G., Bisogno, T., Jaggar, S. I., Hankey, D. J. R., Brown, P., Bridges, D., Ledent, C., Bifulco, M., Rice, A. S. C., Di Marzo, V., & Baker, D. (2002). Arvanil-induced inhibition of spasticity and persistent pain: evidence for therapeutic sites of action different from the vanilloid VR1 receptor and cannabinoid CB(1)/CB(2) receptors. European journal of pharmacology, 439(1-3), 83-92.
  10. 188. Martin, M., Ledent, C., Parmentier, M., Maldonado, R., & Valverde, O. (2002). Involvement of CB1 cannabinoid receptors in emotional behaviour. Psychopharmacologia, 159(4), 379-387. doi:10.1007/s00213-001-0946-5
  11. 189. Morrison, R. R., Talukder, M. A. H., Ledent, C., & Mustafa, S. J. (2002). Cardiac effects of adenosine in A(2A) receptor knockout hearts: uncovering A(2B) receptors. American journal of physiology. Heart and circulatory physiology, 282(2), H437-H444. doi:10.1152/ajpheart.00723.2001
  12. 190. Varma, N., Carlson, G. C., Ledent, C., & Alger, B. E. (2001). Metabotropic glutamate receptors drive the endocannabinoid system in hippocampus. The Journal of neuroscience, 21(24), RC188.
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 Suivant >>